|
Market Closed -
Nasdaq
21:00:00 04/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 151.00 USD | -0.15% |
|
+3.65% | +23.02% |
| 09-03 | AbbVie's blood cancer therapy lowers disease progression, death risk in trial | RE |
| 09-01 | Global pharma companies that have publicly announced Trump drug pricing agreements | RE |
Chart calendar Gilead Sciences, Inc.
Upcoming events on Gilead Sciences, Inc.
| 15/09/2026 | Ex-dividend date - 0.82 USD | 05:00 |
Past events on Gilead Sciences, Inc.
| 04/08/2026 | Earnings presentation | 21:30 |
| 04/08/2026 | Earnings release - Q2 2026 | |
| 07/05/2026 | Earnings presentation | 21:30 |
| 07/05/2026 | Earnings release - Q1 2026 | |
| 30/04/2026 | Présentation aux Actionnaires / Analystes | 18:00 |
| 30/04/2026 | Annual General Meeting | |
| 07/04/2026 | Information meeting | 21:30 |
| 10/02/2026 | Earnings release - Q4 2025 | |
| 10/02/2026 | Earnings presentation | 21:30 |
| 30/10/2025 | Earnings release - Q3 2025 | |
| 30/10/2025 | Earnings presentation | 20:30 |
Past dividends on Gilead Sciences, Inc.
| 15/06/2026 | Ex-dividend date - 0.82 USD | 05:00 |
| 13/03/2026 | Ex-dividend date - 0.82 USD | 04:00 |
| 15/12/2025 | Ex-dividend date - 0.79 USD | 05:00 |
| 15/09/2025 | Ex-dividend date - 0.79 USD | 05:00 |
Annual results
| Fiscal Period | December | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 27 116 27 083 0.12% | 28 754 28 310 1.57% | 29 443 29 205 0.82% | 30 688 | 32 679 | 34 344 |
|
EBITDA Million USD | Released Forecast Spread | 13 177 13 123 0.41% | 11 287 10 600 6.49% | 15 953 15 971 -0.11% | 7 859 | 17 834 | 18 324 |
|
EBIT Million USD | Released Forecast Spread | 10 484 10 687 -1.9% | 8 520 8 238 3.42% | 13 193 13 223 -0.23% | 3 226 | 15 830 | 16 887 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 6 859 7 323 -6.33% | 690 498 38.57% | 9 796 10 031 -2.34% | -1 831 | 12 298 | 13 126 |
|
Net income Million USD | Released Forecast Spread | 5 665 5 872 -3.52% | 480 282 70.44% | 8 510 8 235 3.34% | -4 275 | 10 275 | 10 917 |
|
EPS USD | Released Forecast Spread | 4,50 4,69 -3.96% | 0,38 0,10 274.46% | 6,78 6,82 -0.56% | -3,27 | 8,02 | 8,70 |
| Announcement Date | 06/02/24 | 11/02/25 | 10/02/26 | - |
Quarterly results
| Fiscal Period | June | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | 2026 Q3 | 2026 Q4 | 2027 Q1 | 2027 Q2 | 2027 Q3 | 2027 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 7 569 7 154 5.8% | 6 667 6 813 -2.14% | 7 082 6 964 1.69% | 7 769 7 459 4.16% | 7 925 7 681 3.18% | 6 960 6 929 0.44% | 7 803 7 402 5.41% | 7 760 | 8 130 | 7 465 | 8 092 | 8 291 | 8 892 |
|
EBITDA Million USD | Released Forecast Spread | 3 807 3 255 16.94% | 3 589 3 423 4.85% | 3 981 4 110 -3.13% | 4 607 4 587 0.44% | 3 776 4 359 -13.38% | 3 956 3 557 11.2% | -6 631 -7 334 9.58% | 4 195 | 4 323 | ||||
|
EBIT Million USD | Released Forecast Spread | 3 114 2 876 8.27% | 2 893 2 825 2.4% | 3 290 3 235 1.71% | 3 921 3 482 12.6% | 3 089 3 072 0.55% | 3 267 3 093 5.62% | -7 329 -8 023 8.65% | 3 608 | 3 664 | 3 142 | 3 819 | 4 049 | 4 760 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 2 168 2 043 6.14% | 1 649 2 068 -20.24% | 2 429 2 355 3.14% | 3 641 2 628 38.56% | 2 078 2 338 -11.11% | 2 580 2 236 15.38% | -10 254 -8 918 -14.99% | 2 841 | 2 976 | ||||
|
Net income Million USD | Released Forecast Spread | 1 783 1 605 11.1% | 1 315 1 533 -14.2% | 1 960 1 898 3.24% | 3 052 2 098 45.48% | 2 183 1 819 20% | 2 021 1 944 3.95% | -10 496 -9 647 -8.8% | 2 034 | 2 222 | ||||
|
EPS USD | Released Forecast Spread | 1,42 1,19 19.08% | 1,04 1,26 -17.23% | 1,56 1,48 5.12% | 2,43 1,69 43.48% | 1,74 1,54 12.68% | 1,61 1,58 1.86% | -8,45 -7,76 -8.89% | 1,68 | 1,88 | 1,69 | 1,81 | 1,88 | 2,26 |
| Announcement Date | 11/02/25 | 24/04/25 | 07/08/25 | 30/10/25 | 10/02/26 | 07/05/26 | 04/08/26 | - | - | - | - | - | - |
| 07/09/2026 |  | Présentation aux Actionnaires / Analystes | |
| 07/09/2026 | | Extraordinary General Meeting | 07:30 |
| 07/09/2026 | | Extraordinary General Meeting | 07:30 |
| 07/09/2026 | | Extraordinary General Meeting | 07:30 |
| 07/09/2026 | | Information meeting | 05:30 |
| 07/09/2026 | | Extraordinary General Meeting | 07:00 |
| 07/09/2026 | | Earnings presentation | 08:00 |
| 07/09/2026 | | Extraordinary General Meeting | 07:30 |
| 08/09/2026 | | Analyst/Investor Day | 13:30 |
| 08/09/2026 | | Extraordinary General Meeting | 07:30 |
Past sector events for Gilead Sciences, Inc.
| Today | | Extraordinary General Meeting | |
| 04/09/2026 | | Ex-dividend date - 0.526 CNY | 05:00 |
| 04/09/2026 | | Earnings presentation | 08:00 |
| 04/09/2026 | | Earnings presentation | 03:30 |
| 04/09/2026 | | Ex-dividend date - 3.6 INR | 05:00 |
| 04/09/2026 | | Présentation aux Actionnaires / Analystes | |
| 04/09/2026 | | Ex-dividend date - 0.6 INR | 05:00 |
| 04/09/2026 | | Extraordinary General Meeting | 07:30 |
| 04/09/2026 | | Earnings presentation | 08:00 |
| 04/09/2026 | | Extraordinary General Meeting | 07:45 |
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Stocks
- GILD Stock
- Calendar Gilead Sciences, Inc.
Select your edition
All financial news and data tailored to specific country editions
